05 Mar 2015

BritLofex (Lofexidine hydrochloride) - United Kingdom

ATC: N07BC
NERVOUS SYSTEM
OTHER NERVOUS SYSTEM DRUGS
DRUGS USED IN ADDICTIVE DISORDERS
DRUGS USED IN OPIOID DEPENDENCE
BritLofex

Generic Matches for Lofexidine hydrochloride (1)
BritLofex Tablets 0.2mg

Last Updated on 05 Mar 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

BritLofex Indication

To relieve symptoms in patients undergoing opioid detoxification.

 

BritLofex Generic Name

Lofexidine hydrochloride

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - BritLofex Tablets 0.2mg (external site)

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately.

BritLofex Marketing Information

BritLofex Generic Name
Lofexidine hydrochloride
Marketing Company
Britannia Pharmaceuticals Limited
Drug Type
POM
Date of Issue, Marketing Authority 01/10/1990

Related Drugs - Psychiatry/Mental Health

Back to top